Welcome to SuperLan Chemical Co.,Ltd.
Home > Products > Apoptosis > JAK > Bcl-2 > BAM7

BAM7

(CAS No:331244-89-4)
BAM 7 is a direct and selective activator of proapoptotic Bax with EC50 of 3.3 μM.
CAS No:331244-89-4
Molecular Weight(MW):405.47
Purity:98%
Specification:500mg;1g;5g;10g;50g;100g
Price and large packaging, please e-mail consultation:info@SuperLan-chem.com
QC Documents
 COA  MSDS  HPLC  NMR
ChemicalInfomation
CAS No: 331244-89-4
Molecular formula(MF) C21H19N5O2S
Molecular Weight(MW): 405.47
Alias
Solubility
In vitro DMSO 2 mg/mL (4.93 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
Biological Activity
Description BAM 7 is a direct and selective activator of proapoptotic Bax with EC50 of 3.3 μM.
Features Does not interact with the BH3-binding pocket of antiapoptotic proteins or proapoptotic BAK and induces cell death in a BAX-dependent fashion.
Targets
Bax [1]
3.3 μM(EC50)
In vitro

BAM7 directly binds the previously uncharacterized BH3-binding groove at the N-terminal face of BAX. BAM7 is selective for the BH3-binding groove at the N-terminal face of BAX. BAM7 directly interacts with BAX at the very surface used by the BIM BH3 helix to trigger BAX activation. BAM7 results in functional BAX activation. BAM7 triggers the conversion of BAX from monomer to oligomer in a dose- and time-responsive manner, the kinetics of which approach saturation at a 1:8 dose ratio of BAX:BAM7. BAM7 triggers in vitro BAX oligomerization, BAX-mediated pore formation and BAX-dependent cell death. BAM7 selectively induces BAX-mediated apoptosis by triggering the hallmark features of intracellular BAX activation. BAM7 only kills the cell line that contains BAX, eliciting the biochemical and morphologic features of BAX-mediated apoptosis. [1]